Brief

Healthcare is among the most penalized sectors when it comes to FCPA enforcement. Pharmaceutical, medical supply, and medical technology companies face extensive exposure to government officials due to high volumes of sales to government end-users and a heightened need for regulatory approvals. In addition to these typical FCPA risk factors,...

As companies work to rebuild global supply chains, PSA examines the case of e.l.f. Cosmetics, Inc. and its fine for sanctions violations. The DOJ found that these violations occurred because of a “largely inadequate” compliance program. The individual unit cost of the items were low,  and only limited elements of...

Whistleblower response is an increasingly important part of every company’s compliance environment, with a growing list of countries around the world requiring whistleblower protocols. Whistleblower allegations demand special attention from a company’s decisionmakers and present a unique set of investigative challenges. Every company should have a robust process to respond...